{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:50:03Z","timestamp":1784019003946,"version":"3.55.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["151540"],"award-info":[{"award-number":["151540"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ceca.2014.07.008","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T03:15:54Z","timestamp":1406085354000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Functional and structural impact of pirfenidone on the alterations of cardiac disease and diabetes mellitus"],"prefix":"10.1016","volume":"56","author":[{"given":"Guillermo","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Stephanie","family":"Osornio-Gardu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick Benjam\u00edn","family":"R\u00edos-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ramos-Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2014.07.008_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","article-title":"Diabetic cardiomyopathy: the search for a unifying hypothesis","volume":"98","author":"Poornima","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0010","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2014.07.008_bib0015","unstructured":"S.M. Gadekar, 5-Methyl-1-phenyl-2-(1H)-pyridone compositions and methods of use, US patent no. 3,974,281 A, 1976."},{"key":"10.1016\/j.ceca.2014.07.008_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1755-1536-3-16","article-title":"The multifaceted role of pirfenidone and its novel targets","volume":"3","author":"Mac\u00edas-Barrag\u00e1n","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.ceca.2014.07.008_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev. Off. J. Eur. Respir. Soc."},{"key":"10.1016\/j.ceca.2014.07.008_bib0030","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2165\/11207710-000000000-00000","article-title":"Pirfenidone","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ceca.2014.07.008_bib0035","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.01050207","article-title":"Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis","volume":"2","author":"Cho","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.2010101049","article-title":"Pirfenidone for diabetic nephropathy","volume":"22","author":"Sharma","year":"2011","journal-title":"J. Am. Soc. Nephrol. \u2013 JASN"},{"key":"10.1016\/j.ceca.2014.07.008_bib0045","unstructured":"ClinicalTrials.gov (n.d.), Pirfenidone to Treat Hypertrophic Cardiomyopathy \u2013 Clinical Trials Studies, http:\/\/clinicaltrials.gov\/show\/NCT00011076 (accessed 04.03.14)."},{"key":"10.1016\/j.ceca.2014.07.008_bib0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2147\/VHRM.S3985","article-title":"Role of TGF-beta on cardiac structural and electrical remodeling","volume":"4","author":"Ramos-Mondrag\u00f3n","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ceca.2014.07.008_bib0055","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1161\/01.CIR.0000013956.95796.74","article-title":"Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: management of cardiovascular-renal complications","volume":"105","author":"Bonow","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2014.07.008_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/157340312803760749","article-title":"Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions","volume":"8","author":"Asghar","year":"2012","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.ceca.2014.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","article-title":"Molecular physiology of cardiac repolarization","volume":"85","author":"Nerbonne","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ceca.2014.07.008_bib0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/fca.12.78","article-title":"New directions in antiarrhythmic drug therapy for atrial fibrillation","volume":"9","author":"Heijman","year":"2013","journal-title":"Future Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ceca.2014.07.008_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0008-6363(97)00037-0","article-title":"Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased","volume":"34","author":"Feuvray","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/jmcc.1997.0615","article-title":"Alteration of intracellular Na+ during ischemia in diabetic rat hearts: the role of reduced activity in Na+\/H+ exchange against stunning","volume":"30","author":"Imahashi","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0090","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1006\/jmcc.2000.1151","article-title":"Slowly inactivating component of sodium current in ventricular myocytes is decreased by diabetes and partially inhibited by known Na(+)-H(+)exchange blockers","volume":"32","author":"Chattou","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12012-012-9192-9","article-title":"Intracellular levels of Na(+) and TTX-sensitive Na(+) channel current in diabetic rat ventricular cardiomyocytes","volume":"13","author":"Bilginoglu","year":"2013","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0022-2828(92)91098-P","article-title":"Action potentials and potassium currents in rat ventricular muscle during experimental diabetes","volume":"24","author":"Magyar","year":"1992","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1113\/jphysiol.1993.sp019866","article-title":"Calcium and potassium currents in ventricular myocytes isolated from diabetic rats","volume":"470","author":"Jourdon","year":"1993","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.RES.74.4.620","article-title":"Short-term diabetes alters K+ currents in rat ventricular myocytes","volume":"74","author":"Shimoni","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/bbrc.2001.4825","article-title":"Downregulation of K+ channel genes expression in type I diabetic cardiomyopathy","volume":"283","author":"Qin","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2014.07.008_bib0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.lfs.2006.03.014","article-title":"DITPA restores the repolarizing potassium currents Itof and Iss in cardiac ventricular myocytes of diabetic rats","volume":"79","author":"Ferrer","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ceca.2014.07.008_bib0125","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12011-012-9350-8","article-title":"Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia","volume":"148","author":"Aydemir","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/chan.4.6.12870","article-title":"T-type calcium channel expression and function in the diseased heart","volume":"4","author":"Cribbs","year":"2010","journal-title":"Channels Austin Tex."},{"key":"10.1016\/j.ceca.2014.07.008_bib0140","doi-asserted-by":"crossref","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0145","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/01.PDR.0000155756.89681.3C","article-title":"T-type Ca2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation","volume":"57","author":"Li","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation\u2013contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ceca.2014.07.008_bib0155","series-title":"Excitation\u2013Contraction Coupling and Cardiac Contractile Force","author":"Bers","year":"2001"},{"key":"10.1016\/j.ceca.2014.07.008_bib0160","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1242\/jcs.03223","article-title":"Calcium signaling during excitation\u2013contraction coupling in mammalian atrial myocytes","volume":"119","author":"Bootman","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ceca.2014.07.008_bib0165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ceca.2014.07.008_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.018","article-title":"Cardiac SERCA2A\/B: therapeutic targets for heart failure","volume":"724","author":"Shareef","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.physiol.62.1.111","article-title":"Sodium-calcium exchange: a molecular perspective","volume":"62","author":"Philipson","year":"2000","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0180","first-page":"E202","article-title":"Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats","volume":"253","author":"Makino","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00223194","article-title":"Na+\/Ca2+ exchange of isolated sarcolemmal membrane: effects of insulin, oxidants and insulin deficiency","volume":"83","author":"Kato","year":"1988","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ceca.2014.07.008_bib0190","doi-asserted-by":"crossref","first-page":"C1165","DOI":"10.1152\/ajpcell.1991.260.6.C1165","article-title":"Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation","volume":"260","author":"Allo","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-201x.1999.00547.x","article-title":"Decrease in sodium\u2013calcium exchange and calcium currents in diabetic rat ventricular myocytes","volume":"166","author":"Chattou","year":"1999","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ceca.2014.07.008_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1469-7793.2000.00085.x","article-title":"Diminished function and expression of the cardiac Na+\u2013Ca2+ exchanger in diabetic rats: implication in Ca2+ overload","volume":"527","author":"Hattori","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0205","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.00313.2002","article-title":"Defective intracellular Ca2+ signaling contributes to cardiomyopathy in type 1 diabetic rats","volume":"283","author":"Choi","year":"2002","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0210","first-page":"1035","article-title":"Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy","volume":"17","author":"Ligeti","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ceca.2014.07.008_bib0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0022-2828(81)90318-7","article-title":"Depressed cardiac sarcoplasmic reticular function from diabetic rats","volume":"13","author":"Penpargkul","year":"1981","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0220","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1152\/ajpendo.1983.244.6.E528","article-title":"Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy","volume":"244","author":"Ganguly","year":"1983","journal-title":"Am. J. Physiol. \u2013 Endocrinol. Metab."},{"key":"10.1016\/j.ceca.2014.07.008_bib0225","doi-asserted-by":"crossref","first-page":"H969","DOI":"10.1152\/ajpheart.1983.245.6.H969","article-title":"Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats","volume":"14","author":"Lopaschuk","year":"1983","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0230","first-page":"H540","article-title":"Alterations in cardiac sarcolemmal Ca2+ pump activity during diabetes mellitus","volume":"252","author":"Heyliger","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0235","doi-asserted-by":"crossref","first-page":"H2082","DOI":"10.1152\/ajpheart.1994.266.5.H2082","article-title":"Cellular functions of diabetic cardiomyocytes: contractility, rapid-cooling contracture, and ryanodine binding","volume":"266","author":"Yu","year":"1994","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0240","first-page":"H1529","article-title":"Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats","volume":"270","author":"Lagadic-Gossmann","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0245","doi-asserted-by":"crossref","first-page":"H1137","DOI":"10.1152\/ajpheart.2001.281.3.H1137","article-title":"Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts","volume":"281","author":"Zhong","year":"2001","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2000.1107","article-title":"Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+)channel mRNA in streptozotocin-induced diabetic rat heart","volume":"32","author":"Teshima","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0255","doi-asserted-by":"crossref","first-page":"e39893","DOI":"10.1371\/journal.pone.0039893","article-title":"Role of ER stress in ventricular contractile dysfunction in type 2 diabetes","volume":"7","author":"Takada","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ceca.2014.07.008_bib0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diabetes.53.2.463","article-title":"Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase","volume":"53","author":"Bidasee","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ceca.2014.07.008_bib0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/bbrc.1994.2156","article-title":"Cardiac sarcoplasmic reticulum Ca(2+)-ATPase expression in streptozotocin-induced diabetic rat heart","volume":"203","author":"Zarain-Herzberg","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2014.07.008_bib0270","doi-asserted-by":"crossref","first-page":"C772","DOI":"10.1152\/ajpcell.00086.2005","article-title":"Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance","volume":"291","author":"Vasanji","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yjmcc.2005.03.014","article-title":"Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats","volume":"39","author":"Wold","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0280","doi-asserted-by":"crossref","first-page":"H1344","DOI":"10.1152\/ajpheart.00211.2013","article-title":"Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome","volume":"305","author":"Balderas-Villalobos","year":"2013","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db10-1145","article-title":"Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes","volume":"60","author":"Shao","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ceca.2014.07.008_bib0290","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2337\/diabetes.54.11.3082","article-title":"Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart","volume":"54","author":"Yaras","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ceca.2014.07.008_bib0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2261-13-51","article-title":"ACE-inhibition, but not weight reduction restores cardiomyocyte response to \u03b2-adrenergic stimulation in the metabolic syndrome","volume":"13","author":"Nevelsteen","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ceca.2014.07.008_bib0300","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diabetes.55.03.06.db05-1284","article-title":"Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db\/db type 2 diabetic mice","volume":"55","author":"Pereira","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ceca.2014.07.008_bib0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1024738706470","article-title":"Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts","volume":"249","author":"Bidasee","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ceca.2014.07.008_bib0310","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1124\/mol.60.6.1356","article-title":"Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats","volume":"60","author":"Bidasee","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0315","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","article-title":"Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure","volume":"114","author":"Lee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2014.07.008_bib0320","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","article-title":"Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats","volume":"133","author":"Miric","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0325","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjp.0704539","article-title":"Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats","volume":"135","author":"Mirkovic","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0330","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.hrthm.2010.04.030","article-title":"Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias","volume":"7","author":"Nguyen","year":"2010","journal-title":"Heart Rhythm Off. J. Heart Rhythm Soc."},{"key":"10.1016\/j.ceca.2014.07.008_bib0335","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/hr.2011.139","article-title":"The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice","volume":"35","author":"Yamazaki","year":"2012","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"key":"10.1016\/j.ceca.2014.07.008_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000351179","article-title":"Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation","volume":"126","author":"Wang","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.ceca.2014.07.008_bib0345","doi-asserted-by":"crossref","first-page":"e28134","DOI":"10.1371\/journal.pone.0028134","article-title":"In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion","volume":"6","author":"Shi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ceca.2014.07.008_bib0350","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtcvs.2005.04.012","article-title":"Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model","volume":"130","author":"Liu","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ceca.2014.07.008_bib0355","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/TP.0b013e3181ae3392","article-title":"Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses","volume":"88","author":"Visner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ceca.2014.07.008_bib0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(02)01757-0","article-title":"Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock","volume":"446","author":"Oku","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01758-2","article-title":"A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level","volume":"446","author":"Nakazato","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0370","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2004.07.007","article-title":"Pirfenidone inhibits the induction of iNOS stimulated by interleukin-1beta at a step of NF-kappaB DNA binding in hepatocytes","volume":"41","author":"Nakanishi","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0375","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2003.09.023","article-title":"Pirfenidone prevents endotoxin-induced liver injury after partial hepatectomy in rats","volume":"40","author":"Tsuchiya","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2008.06.110","article-title":"Potent antioxidant role of pirfenidone in experimental cirrhosis","volume":"595","author":"Salazar-Montes","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0385","first-page":"169","article-title":"Effects of pirfenidone on the generation of reactive oxygen species in vitro","volume":"18","author":"Giri","year":"1999","journal-title":"J. Environ. Pathol. Toxicol. Oncol.: Off. Organ Int. Soc. Environ. Toxicol. Cancer"},{"key":"10.1016\/j.ceca.2014.07.008_bib0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1007023532508","article-title":"Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals","volume":"204","author":"Misra","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ceca.2014.07.008_bib0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2008.04.093","article-title":"Superoxide scavenging activity of pirfenidone-iron complex","volume":"372","author":"Mitani","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2014.07.008_bib0400","series-title":"Diabetes and the Kidney","author":"Lai","year":"2011"},{"key":"10.1016\/j.ceca.2014.07.008_bib0405","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0272-6386(99)70037-5","article-title":"Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients","volume":"34","author":"Sharma","year":"1999","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.ceca.2014.07.008_bib0410","first-page":"S239","article-title":"Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy","volume":"63","author":"Shimizu","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ceca.2014.07.008_bib0415","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0420","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","article-title":"Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1","volume":"94","author":"Verheule","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mus.20590","article-title":"Long-term administration of pirfenidone improves cardiac function in mdx mice","volume":"34","author":"Van Erp","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ceca.2014.07.008_bib0430","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cvr\/cvs248","article-title":"Chronic potentiation of cardiac L-type Ca(2+) channels by pirfenidone","volume":"96","author":"Ramos-Mondrag\u00f3n","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0435","doi-asserted-by":"crossref","first-page":"H622","DOI":"10.1152\/ajpheart.00781.2006","article-title":"Transforming growth factor-beta1 decreases cardiac muscle L-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA","volume":"292","author":"Avila","year":"2007","journal-title":"Am. J. Physiol. \u2013 Heart Circ. Physiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0440","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.85.5.428","article-title":"Atrial L-type Ca2+ currents and human atrial fibrillation","volume":"85","author":"Van Wagoner","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0445","doi-asserted-by":"crossref","first-page":"e83033","DOI":"10.1371\/journal.pone.0083033","article-title":"The TGFB1 functional polymorphism rs1800469 and susceptibility to atrial fibrillation in two Chinese Han populations","volume":"8","author":"Zheng","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ceca.2014.07.008_bib0450","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cvr\/cvm022","article-title":"Pro-oxidant effect of transforming growth factor-beta1 mediates contractile dysfunction in rat ventricular myocytes","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0455","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0460","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0465","unstructured":"Pirfenidone In Idiopathic Pulmonary Fibrosis: Drugs (n.d.), http:\/\/adisonline.com\/drugs\/Fulltext\/2011\/71130\/Pirfenidone__In_Idiopathic_Pulmonary_Fibrosis.6.aspx (accessed 10.01.12)."},{"key":"10.1016\/j.ceca.2014.07.008_bib0470","first-page":"117","article-title":"Pirfenidone. First, do no harm","volume":"22","year":"2013","journal-title":"Prescrire Int."},{"key":"10.1016\/j.ceca.2014.07.008_bib0475","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2460\/ajvr.69.7.952","article-title":"Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses","volume":"69","author":"Braim","year":"2008","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0480","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2460\/ajvr.70.8.1031","article-title":"Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia","volume":"70","author":"Poulin Braim","year":"2009","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ceca.2014.07.008_bib0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","article-title":"Can we rationally design promiscuous drugs?","volume":"16","author":"Hopkins","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ceca.2014.07.008_bib0490","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/14656566.2013.758250","article-title":"The evolving pharmacotherapy of pulmonary fibrosis","volume":"14","author":"Lota","year":"2013","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416014001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416014001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:20:57Z","timestamp":1758918057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416014001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0143416014001122"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2014.07.008","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional and structural impact of pirfenidone on the alterations of cardiac disease and diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2014.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}